Article info
Coronary artery disease
Original research article
Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease
- Correspondence to Suzette J Bielinski, Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Harwick Building 6-56, 200 First Street Southwest, Rochester, MN 55905, USA; bielinski.suzette{at}mayo.edu
Citation
Hepatocyte growth factor demonstrates racial heterogeneity as a biomarker for coronary heart disease
Publication history
- Received August 11, 2016
- Revised January 19, 2017
- Accepted January 27, 2017
- First published June 1, 2017.
Online issue publication
January 18, 2021
Article Versions
- Previous version (14 July 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.